U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT07490327) titled 'Assessment of Dutasteride Topical Solution in Male Androgenetic Alopecia' on March 13.
Brief Summary: This is a randomized, open-label phase 1/2a study designed to evaluate the pharmacokinetics, pharmacodynamics, and safety of AD-303A (topical formulation) and AD-3031 in male patients with androgenetic alopecia. The study aims to compare pharmacological characteristics and safety profiles to support dose selection for further clinical development.
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Androgenetic Alopecia
Intervention:
DRUG: AD-303A
Topical AD-303A applied to the scalp according to the study pr...